NANJING Sample Technology Company (01708.HK) has published an announcement providing supplementary information to the capital injection into its 50:50 JV company it formed with Nanjing Pharmaceutical Company Limited.

The JV company's profit after taxation for the year ended 31 December 2011 was RMB3.9 million and its net assets as at 31 December 2010 was RMB152 million. Its net asset value as at 30 June 2011 based on its unaudited management account was RMB260.146 million.